Gene · 26871
Papers1,946
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,946
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in targeting estrogen synthesis and receptors in patients with endometriosis. | Expert Opin Investig Drugs | 2022 | 36529967 | PubTator, text mining | PubMed |
| Structural basis of SNAPc-dependent snRNA transcription initiation by RNA polymerase II. | Nat Struct Mol Biol | 2022 | 36424526 | PubTator, text mining | PubMed |
Weak Noncovalent Interactions in Three Closely Related Adamantane-Linked 1,2,4-Triazole N-Mannich Bases: Insights from Energy Frameworks, Hirshfeld Surface Analysis, In Silico 11β-HSD1 Molecular Docking and ADMET Prediction. | Molecules | 2022 | 36364230 | PubTator, text mining | PubMed |
Selective Inhibition of 11beta-Hydroxysteroiddehydrogenase-1 with BI 187004 in Patients with Type 2 Diabetes and Overweight or Obesity: Safety, Pharmacokinetics, and Pharmacodynamics After Multiple Dosing Over 14 Days. | Exp Clin Endocrinol Diabetes | 2022 | 36343645 | PubTator, text mining | PubMed |
| Human PRPF39 is an alternative splicing factor recruiting U1 snRNP to weak 5' splice sites. | RNA | 2022 | 36316087 | PubTator, text mining | PubMed |
| Bioactivity-Guided Fractionation and Identification of Antidiabetic Compound of Syzygium polyanthum (Wight.)'s Leaf Extract in Streptozotocin-Induced Diabetic Rat Model. | Molecules | 2022 | 36296407 | PubTator, text mining | PubMed |
| 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases. | J Clin Med | 2022 | 36294507 | PubTator, text mining | PubMed |
| Applications of the Multiattribute Decision-Making for the Development of the Tourism Industry Using Complex Intuitionistic Fuzzy Hamy Mean Operators. | Comput Intell Neurosci | 2022 | 36262624 | PubTator, text mining | PubMed |
| The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. | Cancer Res | 2022 | 36251389 | PubTator, text mining | PubMed |
| Transcriptome-wide m6A methylome analysis uncovered the changes of m6A modification in oral pre-malignant cells compared with normal oral epithelial cells. | Front Oncol | 2022 | 36249071 | PubTator, text mining | PubMed |
| Mutation and Interaction Analysis of the Glycoprotein D and L and Thymidine Kinase of Pseudorabies Virus. | Int J Mol Sci | 2022 | 36232898 | PubTator, text mining | PubMed |
| Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular docking and conceptual DFT studies. | PLoS One | 2022 | 36201520 | PubTator, text mining | PubMed |
| Non-invasive in vivo assessment of 11β-hydroxysteroid dehydrogenase type 1 activity by 19F-Magnetic Resonance Spectroscopy. | Sci Rep | 2022 | 36175417 | PubTator, text mining | PubMed |
| Development and structure-activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors. | Nat Prod Bioprospect | 2022 | 36131216 | PubTator, text mining | PubMed |
| 11β-hydroxysteroid dehydrogenases and biomarkers in fetal development. | Toxicology | 2022 | 36096318 | PubTator, text mining | PubMed |
| Effects of HSD11B1 knockout and overexpression on local cortisol production and differentiation of mesenchymal stem cells. | Front Bioeng Biotechnol | 2022 | 36091434 | PubTator, text mining | PubMed |
| U1 snRNP proteins promote proximal alternative polyadenylation sites by directly interacting with 3' end processing core factors. | J Mol Cell Biol | 2022 | 36073763 | PubTator, text mining | PubMed |
| Cortisol Stimulates Local Progesterone Withdrawal Through Induction of AKR1C1 in Human Amnion Fibroblasts at Parturition. | Endocrinology | 2022 | 36048433 | PubTator, text mining | PubMed |
| BRAT1 links Integrator and defective RNA processing with neurodegeneration. | Nat Commun | 2022 | 36028512 | PubTator, text mining | PubMed |
| 11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases. | Int J Mol Sci | 2022 | 36012251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26871/papers?page=5